Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia

NCT00372619 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00372619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of CLOLAR® (Clofarabine, IND# 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2007
Completion date
August 31, 2012
Enrollment
74 (actual)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia